Company Analysis
Sign in

Castle Biosciences, Inc. (CSTL)

Nasdaq: CSTL · Services-Medical Laboratories · Friendswood, TX · filing with the SEC since 2008
Full chart Alerts Compare
Grade6.1
◀ Past 5.6● Present 7.3▶ Future 5.1
OverviewBusinessFinancialsGradeForecastSentimentOwnershipPeopleFilingsPatents Chart
The companyfiscal 2025, as filed
Revenue$344M+3.7%
Net income-$24.2M-232.4%
Earnings per share$-0.83-233.9%
Operating cash flow$64.3M-0.8%
Cash$117M-2.5%
Debt$9.6M-1.1%
Shareholders’ equity$471M+3.3%
Shares, diluted29.0M-0.9%
Return on equity-5.1%
The recordfrom its filings
Filings in 2026117
Newest filingNov 12 · 144
Annual reportFeb 26, 2026
Quarterly reportNov 5, 2026
Next report due10-K by Mar 16
Insider sales, 12 months$19.0M
Insider buys, 12 months$0.00
Patents granted16
Filer categoryAccelerated filer
Trailing twelve months to Sep 2026Revenue $377MNet income -$23.0MCash from operations $39.7Mthe four newest filed quarters added
Left: the newest annual report, with the change on the year before. Right: counted from the company's own filings with the SEC.
Revenue and net income by fiscal yearRevenueNet income
1819202122232425
As filed, in USD. Nothing here is a forecast.

News

Nov 12, 2026 · SEC EDGAR · Form 4
Insider trade report
Open the filing on sec.gov
Nov 5, 2026 · SEC EDGAR · Form 10-Q
Quarterly report
Open the filing on sec.gov
Nov 5, 2026 · SEC EDGAR · Form 8-K
Results released
Open the filing on sec.gov
Nov 4, 2026 · SEC EDGAR · Form 4
Insider trade report
Open the filing on sec.gov
Oct 30, 2026 · SEC EDGAR · Form 4
Insider trade report
Open the filing on sec.gov
Oct 28, 2026 · SEC EDGAR · Form 4
Insider trade report
Open the filing on sec.gov
An outside story is shown by its headline, its source and its link only. The SI reads the page when you ask it to break one down.
SI Assistanton CSTL · research, not advice